Portal de Periódicos da CAPES

Artigo Acesso aberto Produção Nacional Revisado por pares

BIBTEX RIS

EP04.01-011 Diagnostic Approach and Treatment of Lung Cancer Patients in Portugal: Portuguese Lung Cancer Study Group Survey

2022; Elsevier BV; Volume: 17; Issue: 9 Linguagem: Inglês

10.1016/j.jtho.2022.07.423

1556-1380

F. Estevinho, A. Figueiredo, E. Teixeira, J. Oliveira, A. Pego, A. Barroso, Alice Telles Pires Nogueira de Faria, A. Fernandes, Ana Amélia Macedo Chaves, Ana Maria Pereira Brasilio de Araujo, A. Meleiro, B. Parente, C. Matos, D. Canário, E. Camacho, F. Barata, Giovanna Vasconcellos Câmara, H. Queiroga, JOEL SENA SALES JUNIOR E FILIPE SALVADOR LOPES, J. Mellidez, Leticia de Freitas Barradas, Leonor Fernandes Ferreira, Leonor Fernandes Ferreira, M. Felizardo, Maria Auxiliadora Pereira Figueiredo, Michellia Pereira Soares, M. Lopes, N. Gil, P. Fidalgo, Renan Lucas Freire Gomes, R. Vitorino, S. Valente, S. Silva, Tarcísio Nascimento Cardoso, U. Brito, T. Almodovar,

Lung Cancer Treatments and Mutations

In Portugal, in 2020, 5415 new lung cancer patients were diagnosed and 4797 deaths were caused by lung cancer. Lung cancer ranks third in terms of cancer incidence and is the leading cause of cancer mortality. Early diagnosis, complete and fast patient assessment and staging, multidisciplinary approach, access to personalized medicine, new treatment options and research are essential to improve survival and quality of life. Access to clinical trials is critical for this improvement.The aim of this study is to assess the techniques available to the diagnostic work-up, treatments, the waiting time and the needs perceived by physicians.